Stage IV Cervical Cancer AJCC v6 and v7
3 clinical trials · Condition
◉ Watch Stage IV Cervical Cancer AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer (NCT02921269) | National Cancer Institute (NCI) | 2017-03-10 |
| Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer (NCT03902379) | Rutgers, The State University of New Jersey | 2016-07-27 |
| Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer (NCT02257528) | National Cancer Institute (NCI) | 2015-05-18 |
Track Stage IV Cervical Cancer AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.